Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Human Vaccines & Immunotherapeutics|April 15, 2025
A randomized, open-label study on the effect of nipocalimab on vaccine responses in healthy participantsMarta Cossu, Carolina Bobadilla Mendez, Amanda Jackson, et al.
Annals of the Rheumatic Diseases|April 22, 2014
Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study)Arthur Kavanaugh, Iain B McInnes, Philip Mease, et al.
The New England Journal of Medicine|November 18, 2020
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 DiabetesTeresa Quattrin, Michael J Haller, Andrea K Steck, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1993
Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factorL Santambrogio, G M Hochwald, B Saxena, et al.
Clinical Pharmacology and Therapeutics|February 8, 2025
IQ Survey Results on Current Industry Practices: Part 2-Quantitative Evaluations of Immunogenicity AssessmentSusan Richards, Insa Winzenborg, Doreen Luedtke, et al.
Virology|November 4, 2000
Identification and characterization of a shrimp white spot syndrome virus (WSSV) gene that encodes a novel chimeric polypeptide of cellular-type thymidine kinase and thymidylate kinaseM F Tsai, H T Yu, H F Tzeng, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial SpondyloarthritisAtul Deodhar, Lianne S Gensler, Joachim Sieper, et al.
Lancet (London, England)|November 24, 2025
Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trialGhaith Noaiseh, Kathy L Sivils, Kim Campbell, et al.
Clinical Pharmacology and Therapeutics|January 29, 2025
IQ Survey Results on Current Industry Practices-Part 1: Immunogenicity Risk AssessmentChristine Grimaldi, Susan Richards, Daniel Baltrukonis, et al.
Arthritis Care & Research|October 17, 2015
Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical TrialPaul Emery, Roy M Fleischmann, Ingrid Strusberg, et al.
Pageof 10